Impact of preoperative versus postoperative dialysis on left ventricular assist device outcomes: An analysis from the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support database.
BIVAD, biventricular assist device
CI, confidence interval
ESRD, end-stage renal disease
INTERMACS
INTERMACS, interagency registry for mechanically assisted circulatory support
LVAD
LVAD, left ventricular assist device
OR, odds ratio
STS, Society of Thoracic Surgeons
dialysis
outcomes
renal failure
Journal
JTCVS open
ISSN: 2666-2736
Titre abrégé: JTCVS Open
Pays: Netherlands
ID NLM: 101768541
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
02
03
2021
accepted:
12
01
2022
entrez:
25
8
2022
pubmed:
26
8
2022
medline:
26
8
2022
Statut:
epublish
Résumé
Chronic kidney disease and renal failure are common in patients being considered for left ventricular assist device support. We sought to evaluate the outcomes of patients undergoing left ventricular assist device implantation with preoperative dialysis and those with new-onset postoperative renal failure requiring dialysis. All patients (n = 14,090) undergoing primary left ventricular assist device implantation who were listed in the Interagency Registry for Mechanically Assisted Circulatory Support database (2014-2019) were evaluated. Landmark analysis then stratified patients alive at 1 month by preoperative dialysis and at 1 month postoperatively, preoperative dialysis only, postoperative dialysis only, and no dialysis. Of 14,090 patients undergoing left ventricular assist device implantation, patients on dialysis (400%, 3%) preoperatively had significantly higher mortality at 1 month (18% vs 6%, Preoperative renal failure is associated with 3 times higher mortality and worse morbidity in patients receiving a left ventricular assist device. However, one-third of patients with preoperative dialysis will recover renal function postimplant with similar long-term survival and quality of life as those without dialysis.
Identifiants
pubmed: 36003469
doi: 10.1016/j.xjon.2022.01.005
pii: S2666-2736(22)00014-6
pmc: PMC9390495
doi:
Types de publication
Journal Article
Langues
eng
Pagination
122-143Informations de copyright
© 2022 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.
Références
N Engl J Med. 2001 Nov 15;345(20):1435-43
pubmed: 11794191
N Engl J Med. 2009 Dec 03;361(23):2241-51
pubmed: 19920051
J Heart Lung Transplant. 2006 Apr;25(4):404-8
pubmed: 16563969
J Card Fail. 2016 May;22(5):323-37
pubmed: 26576714
Ann Thorac Surg. 2021 Mar;111(3):881-888
pubmed: 32739256
Clin Nephrol. 2014 Dec;82(6):407-10
pubmed: 23863299
Am J Nephrol. 2020;51(3):172-181
pubmed: 31962311
Heart Lung Circ. 2017 Nov;26(11):1216-1223
pubmed: 28342643
ASAIO J. 2016 May-Jun;62(3):261-7
pubmed: 26735558
Am J Kidney Dis. 2021 Feb;77(2):226-234
pubmed: 32711070
J Heart Lung Transplant. 2013 Dec;32(12):1205-13
pubmed: 24119728
Am J Kidney Dis. 2018 Feb;71(2):257-266
pubmed: 29249390
Ann Thorac Surg. 2020 Mar;109(3):649-660
pubmed: 32115073
Cardiorenal Med. 2019;9(2):100-107
pubmed: 30673661
Clin J Am Soc Nephrol. 2013 Mar;8(3):484-96
pubmed: 23065497
JACC Heart Fail. 2018 Sep;6(9):771-779
pubmed: 30098967
Cureus. 2020 Apr 18;12(4):e7725
pubmed: 32432003
J Heart Lung Transplant. 2018 Jan;37(1):116-123
pubmed: 29174532
Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12):e003268
pubmed: 29246883
JAMA Intern Med. 2018 Feb 1;178(2):204-209
pubmed: 29255896
J Thorac Cardiovasc Surg. 2018 Sep;156(3):1093-1101.e1
pubmed: 30017440